Changes in hospital consumption of opioid and non-opioid analgesics after colorectal endometriosis surgery

Author:

Crestani Adrien1,Gac Marjolaine Le1,Bibaoune Amine1,Dabi Yohann1,Kolanska Kamila1,Ferrier Clément1,Bendifallah Sofiane1,Touboul Cyril1,Darai Emile1

Affiliation:

1. Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University

Abstract

Abstract Background The aim of this study was to analyze postoperative consumption of analgesics during hospitalization following colorectal surgery for endometriosis. Methods: We conducted a retrospective study at Tenon University Hospital, Paris, France from February 2019 to December 2021. Results One hundred sixty-two patients underwent colorectal surgery: 89 (55%) by robotic and 73 (45%) by conventional laparoscopy. The type of procedure had an impact on acetaminophen and nefopam consumed per day: consumption for colorectal shaving, discoid resection and segmental resection was, respectively, 2(0.5), 2.1(0.6), 2.4(0.6) g/day (p = 10 − 3), and 25(7), 30(14), 31(11) mg/day (p = 0.03). The total amount of tramadol consumed was greater following robotic surgery compared with conventional laparoscopy (322(222) mg vs 242(292) mg, p = 0.04). We observed a switch in analgesic consumption over the years: tramadol was used by 70% of patients in 2019 but only by 7.1% in 2021 (p < 10 − 3); conversely, ketoprofen was not used in 2019, but was consumed by 57% of patients in 2021 (p < 10 − 3). A history of abdominal surgery (OR = 0.37 (0.16–0.78, p = 0.011) and having surgery in 2020 rather than in 2019 (OR = 0.10 (0.04–0.24, p < 10− 3)) and in 2021 than in 2019 (OR = 0.08 (0.03–0.20, p < 10− 3)) were the only variables independently associated with the risk of opioid use. Conclusion We found that neither clinical characteristics nor intraoperative findings had an impact on opioid consumption in this setting, and that it was possible to rapidly modify in-hospital analgesic consumption modalities by significantly reducing opioid consumption in favor of NSAIDS or Nefopam.

Publisher

Research Square Platform LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3